<DOC>
	<DOCNO>NCT02948088</DOCNO>
	<brief_summary>TGCT rare disease difficult manage , surgical resection primary treatment currently available . To date disease registry exist little data available detail management patient diffuse TGCT , burden diffuse TGCT patient ( include pain , joint stiffness , swell , reduce mobility quality life ) economic impact diffuse TGCT . This study aim collect data observational disease registry involve intervention patient change investigator treatment decision .</brief_summary>
	<brief_title>Tenosynovial Giant Cell Tumors ( TGCT ) Observational Platform Project</brief_title>
	<detailed_description>GCT rare , benign , potentially locally aggressive recurrent disease . Treatment pattern treatment initiation , continuation change solely discretion physician patient . There attempt influence prescribing pattern individual treat physician . All medication prescribe usual standard care provide study sponsor . Participation study way influence payment reimbursement treatment receive patient study . It responsibility investigator study staff enter relevant patient data require registry electronic Case Report Form ( eCRF ) patient ' medical record . Approximately 15 site 6 European Countries ( France , Germany , Italy , The Netherlands , Spain United Kingdom ) plan participate . The site specialize site treat diffuse TGCT regularly .</detailed_description>
	<mesh_term>Giant Cell Tumors</mesh_term>
	<criteria>Written inform consent participation study ( ICF ) Patients diffuse TGCT ( diagnose histologically ) confirm na√Øve recurrent case</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Tenosynovial Giant Cell Tumors</keyword>
	<keyword>Disease registry</keyword>
	<keyword>Routine clinical practice</keyword>
	<keyword>Real World Evidence</keyword>
</DOC>